Sonoma, EMC to co-market eye care product line
Click Here to Manage Email Alerts
Sonoma Pharmaceuticals and EMC Pharma have entered into a co-marketing agreement to expand their eye care product lines, according to a press release.
Through the agreement, EMC will have the right to sell Sonoma’s over-the-counter Ocucyn (0.01% hypochlorous acid), and Sonoma will sell EMC’s prescription Acuicyn hypochlorous acid-based eyelid and eyelash cleanser, according to the release.
Ocucyn is designed for daily use to reduce itch and irritation, while Acuicyn is used to manage conditions such as dry eye disease and blepharitis. The companies plan to present the products at the American Academy of Ophthalmology annual meeting in October.
“Ocucyn will provide an over-the-counter option for our existing customers in addition to attracting new eye care customers in our distribution channels, which include many government entities,” EMC CEO Eric Bailey said in the release.
“Our partnership with EMC Pharma has been a success for both companies, and we are excited to open up new channels for both Sonoma and EMC with this co-marketing agreement,” Sonoma CEO Amy Trombly said in the release. “Both companies have invested in marketing eye care products, and by coordinating our efforts, we expect to increase sales of both OTC and prescription eye care.”
Read more about
Click Here to Manage Email Alerts